CVS Reaches Deal to Lower Insulin Prices for Patients

CVS Caremark has agreed to settle federal charges that it inflated insulin prices, promising changes that could make the lifesaving diabetes medication more affordable.

The move follows similar action by another major pharmacy manager, signaling real progress on drug pricing.